Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sulfhydryl groups (–SH), present on cysteine residues of cell membrane proteins, play a crucial role in maintaining protein structure, regulating redox-sensitive processes, and mediating cellular interactions. Their reactivity makes them vulnerable to oxidation or chemical modification, impacting membrane properties and contributing to pathologies like hemolytic anemia. These groups are not typically direct therapeutic targets themselves, but rather critical components of protein structure and function that can be modulated indirectly.
Sulfhydryl-reactive crosslinkers (e.g., maleimides, haloacetyls) form stable thioether bonds with –SH moieties via alkylation or participate in disulfide exchange reactions, thereby modifying protein structure and function. Oxidation of sulfhydryl groups leads to disulfide bond formation, altering protein conformation and activity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sulfhydryl Group on Cell Membrane Proteins (-SH).